Read + Share
Amedeo Smart
Independent Medical Education
Tanemoto M. Key questions regarding the SYMPLICITY HTN-3 trial. Lancet 2023;401:1337.PMID: 37087165
Email
LinkedIn
Facebook
Twitter
Privacy Policy